CCL4 is the only predictor for non-responder in GT-1 CHC patients with favorable IL28B genotype when treated with PegIFN/RBV

CCL4 is the only predictor for non-responder in GT-1 CHC patients with favorable IL28B genotype when treated with PegIFN/RBV

Abstract Background Chemokines/cytokines play important roles in the pathogenesis of chronic hepatitis C (CHC). However, their clinical characteristics and implications in treatment responses to pegylated interferon plus ribavirin treatment (PegIFN/RBV) have not been fully illustrated yet. In this s...

Full description

Bibliographic Details
Main Authors: Chia-Chen Lin, Shih-Huan Su, Wen-Juei Jeng, Chien-Hao Huang, Wei Teng, Wei-Ting Chen, Yi-Cheng Chen, Chun-Yen Lin, I-Shyan Sheen
Format: Article
Language:English
Published: BMC 2017-12-01
Series:BMC Gastroenterology
Subjects:
Chemokines
Cytokines
Treatment response
Chronic hepatitis C
Genotype-1
Interleukin-28B polymorphism
Online Access:http://link.springer.com/article/10.1186/s12876-017-0724-4

Internet

http://link.springer.com/article/10.1186/s12876-017-0724-4

Similar Items